CERS
CERS
NASDAQ · Health Care

Cerus Corp

$2.72
+0.69 (+33.99%)
As of May 9, 1:50 AM ET ·
Financial Highlights (FY 2026)
Revenue
228.17M
Net Income
-15,252,350
Gross Margin
59.9%
Profit Margin
-6.7%
Rev Growth
+7.5%
D/E Ratio
1.31
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.9% 59.9% 34.5% 34.5%
Operating Margin -3.7% -3.3% 20.6% 22.0%
Profit Margin -6.7% -6.4% 19.8% 14.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 228.17M 212.29M 130.22M 111.42M
Gross Profit 136.58M 127.08M 44.87M 38.39M
Operating Income -8,465,160 -7,088,429 26.88M 24.51M
Net Income -15,252,350 -12,771,785 25.78M 16.47M
Gross Margin 59.9% 59.9% 34.5% 34.5%
Operating Margin -3.7% -3.3% 20.6% 22.0%
Profit Margin -6.7% -6.4% 19.8% 14.8%
Rev Growth +7.5% +7.5% +7.1% +0.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 143.28M 143.28M 205.04M 167.58M
Total Equity 109.69M 109.69M 201.48M 187.99M
D/E Ratio 1.31 1.31 1.02 0.89
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -4,129,295 -3,649,823 34.32M 27.68M
Free Cash Flow 26.52M 27.45M